These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 24746973)

  • 21. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
    Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
    J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of upgrading and upstaging in patients with low-volume Gleason score 3+4 prostate cancers at biopsy: finding a new group eligible for active surveillance.
    Park HJ; Ha YS; Park SY; Kim YT; Lee TY; Kim JH; Lee DH; Kim WJ; Kim IY
    Urol Int; 2013; 90(3):301-5. PubMed ID: 23391718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients.
    Flammia RS; Hoeh B; Hohenhorst L; Sorce G; Chierigo F; Panunzio A; Tian Z; Saad F; Leonardo C; Briganti A; Antonelli A; Terrone C; Shariat SF; Anceschi U; Graefen M; Chun FKH; Montorsi F; Gallucci M; Karakiewicz PI
    Int Urol Nephrol; 2022 Oct; 54(10):2521-2528. PubMed ID: 35838831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
    Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
    BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy.
    Yamoah K; Walker A; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Dicker AP; Rebbeck TR; Lal P
    Clin Genitourin Cancer; 2015 Apr; 13(2):e65-72. PubMed ID: 25450037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer.
    Filippou P; Welty CJ; Cowan JE; Perez N; Shinohara K; Carroll PR
    Eur Urol; 2015 Sep; 68(3):458-63. PubMed ID: 26138041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
    Shee K; Cowan JE; Washington SL; Shinohara K; Nguyen HG; Cooperberg MR; Carroll PR
    Eur Urol Oncol; 2024 Aug; 7(4):838-843. PubMed ID: 38057193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
    Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
    J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study.
    Deivasigamani S; Adams ES; Stock S; Kotamarti S; Séguier D; Taha T; Howard LE; Aminsharifi A; Jibara G; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Klaassen Z; Guerrios-Rivera L; Freedland SJ; Polascik TJ
    Prostate Cancer Prostatic Dis; 2024 Aug; ():. PubMed ID: 39134653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy.
    Falagario UG; Ratnani P; Lantz A; Jambor I; Dovey Z; Verma A; Treacy PJ; Sobotka S; Martini A; Bashorun H; Ashan M; Wagaskar VG; Lewis S; Cormio L; Carrieri G; Kyprianou N; Mohamed N; Tewari A
    J Urol; 2020 Jul; 204(1):82-90. PubMed ID: 31977261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
    Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
    Cancer; 2011 Oct; 117(20):4651-8. PubMed ID: 21456009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.
    Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM
    Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer.
    Leeman JE; Chen MH; Huland H; Graefen M; D'Amico AV; Tilki D
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1116-e1121. PubMed ID: 31601512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer.
    Morrison BF; Aiken WD; Reid G; Mayhew R; Hanchard B
    Ecancermedicalscience; 2019; 13():971. PubMed ID: 31921342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
    Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
    Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
    Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.